New Age Alpha Advisors LLC Makes New Investment in Avantor, Inc. (NYSE:AVTR)

New Age Alpha Advisors LLC bought a new position in Avantor, Inc. (NYSE:AVTR) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 62,222 shares of the company’s stock, valued at approximately $1,311,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Louisiana State Employees Retirement System lifted its stake in Avantor by 0.3% in the fourth quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company’s stock worth $3,980,000 after acquiring an additional 500 shares during the period. Hantz Financial Services Inc. lifted its position in shares of Avantor by 2.1% in the 3rd quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company’s stock worth $644,000 after purchasing an additional 503 shares during the period. Blue Trust Inc. boosted its stake in shares of Avantor by 6.9% during the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock valued at $170,000 after purchasing an additional 522 shares in the last quarter. Pacer Advisors Inc. increased its holdings in Avantor by 0.5% during the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock valued at $2,103,000 after buying an additional 542 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its stake in Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after buying an additional 625 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 4,907 shares of the firm’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP James Bramwell sold 3,758 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares of the company’s stock, valued at $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by corporate insiders.

Avantor Stock Performance

Shares of NYSE AVTR opened at $16.19 on Monday. The company has a 50 day simple moving average of $18.40 and a two-hundred day simple moving average of $21.35. The stock has a market cap of $11.03 billion, a price-to-earnings ratio of 15.57, a PEG ratio of 1.55 and a beta of 1.30. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 12 month low of $15.37 and a 12 month high of $28.00.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period last year, the business earned $0.22 EPS. As a group, analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analyst Ratings Changes

AVTR has been the subject of several recent research reports. Stifel Nicolaus reduced their price target on Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Monday, February 10th. Cowen reiterated a “buy” rating on shares of Avantor in a report on Tuesday, March 18th. UBS Group reissued a “neutral” rating and set a $25.00 price target (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Morgan Stanley cut their price objective on shares of Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Finally, Citigroup lowered their target price on shares of Avantor from $22.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $25.50.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.